Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
25.50Prev. Close
24.48Volume
53Total traded value
0.00 CrUpper Circuit
29.37Lower Circuit
19.59Fundamentals
| Market Cap | ₹11Cr |
| ROE | 12.99% |
| P/E Ratio(TTM) | 111.27 |
| EPS(TTM) | 0.22 |
| P/B Ratio | 3.49 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.64 |
| Book Value | 7.01 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Unjha Formulations
Unjha Formulations is a pharmaceutical company that manufactures Ayurvedic and Isabgol-based healthcare products, including contract manufacturing for well-known brands like Fybogel. The company focuses on providing affordable healthcare solutions that address real needs, guided by a customer-centric approach to fuel its growth and market presence. The company demonstrated strong financial performance by increasing its profit after tax by a significant 46% in the last fiscal year.;
| Parent Organisation | Unjha Formulations Limited |
| BSE Symbol | 531762 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.75 | ||
| Gland Pharma | NA (0.00%) | 43.16 | ||
| Ajanta Pharma | NA (0.00%) | 34.16 | ||
| Eris Lifesciences | NA (0.00%) | 57.46 |